In its original complaint, Louisiana argued the Biden administration expanded access to mifepristone without properly considering potential safety risks. The state also argued the policy violated the Comstock Act, which generally prohibits sending abortion drugs by mail.
A three-judge panel on the 5th U.S. Circuit Court of Appeals in New Orleans is poised to hear oral arguments next week in a case that could eventually restrict the nationwide distribution of the abortion drug mifepristone.
The court found that dozens of state laws undermined a state constitutional amendment that guaranteed reproductive rights. The state vowed to appeal the finding.
The temporary decision will preserve access nationwide to medication abortion, which has become the most common way of ending pregnancies in the United States.